Research Topics
Species | J S WunderSummaryAffiliation: Samuel Lunenfeld Research Institute Country: Canada Publications
| Collaborators
|
Detail Information
Publications
TP53 mutations and outcome in osteosarcoma: a prospective, multicenter studyJay S Wunder
Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5
J Clin Oncol 23:1483-90. 2005..This is the first prospective study of the prognostic value of somatic TP53 mutations in patients with newly diagnosed extremity osteosarcoma...
Opportunities for improving the therapeutic ratio for patients with sarcomaJay S Wunder
University Musculoskeletal Oncology Unit and Program in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Canada
Lancet Oncol 8:513-24. 2007..Research in stem-cell biology and nanotechnology holds promise for additional novel treatment options in the future...
Comparison of two methods of reconstruction for primary malignant tumors at the knee: a sequential cohort studyJ S Wunder
University Musculoskeletal Oncology Unit, Mount Sinai Hospital, and the Department of Surgery, University of Toronto, Toronto, Canada
J Surg Oncol 77:89-99; discussion 100. 2001....
The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcomaJ S Wunder
Department of Surgery, Memorial Sloan Kettering Cancer Center, Cornell University Medical College, New York City, NY 10021, USA
J Bone Joint Surg Am 80:1020-33. 1998..These indicators should be used to identify patients who are at high risk for metastasis as such patients may be candidates for more intensive or novel therapies...
MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter studyJ S Wunder
Samuel Lunenfeld Research Institute and the University Musculoskeletal Oncology Unit, Mount Sinai Hospital, Toronto, Ontario, Canada
J Clin Oncol 18:2685-94. 2000..This study represents the first prospective assessment of the prognostic value of MDR1 mRNA expression in patients with newly diagnosed extremity osteosarcoma...
Predictors of functional outcomes following limb salvage surgery for lower-extremity soft tissue sarcomaA M Davis
University Musculoskeletal Oncology Unit, Mount Sinai Hospital and the University of Toronto, Toronto, Canada
J Surg Oncol 73:206-11. 2000....
Allograft reconstruction of the acetabulum after resection of stage-IIB sarcoma. Intermediate-term resultsR S Bell
University Musculoskeletal Oncology Unit, Mount Sinai Hospital and the University of Toronto, Ontario, Canada
J Bone Joint Surg Am 79:1663-74. 1997..In the present series, more than half of the patients either died or had failure of the reconstruction...
Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrenceC H Gerrand
Mount Sinai Hospital, Toronto, Canada
J Bone Joint Surg Br 83:1149-55. 2001..2% and 3.6%) and the two high-risk groups (31.6% and 37.5%). This classification therefore provides useful information about the incidence of local recurrence after positive-margin resection...
p53 missense but not truncation mutations are associated with low levels of p21(CIP1/WAF1) mRNA expression in primary human sarcomasS Mousses
Samuel Lunenfeld Research Institute, Department of Laboratory Medicine and Pathobiology, Mount Sinai Hospital, Toronto, Ontario, Canada
Br J Cancer 84:1635-9. 2001..The results of this study suggest that different types of p53 mutations can have different effects on the expression of downstream genes such as p21(CIP1/WAF1) in human sarcomas...
Instability after major tumor resection: prevention and treatmentC H Gerrand
The University Musculoskeletal Oncology Unit, Mount Sinai Hospital, Toronto, Ontario, Canada
Orthop Clin North Am 32:697-710, ix-x. 2001..The options for reconstruction in each area are discussed along with a review of the literature and a description of the authors' preferred approach...
The influence of anatomic location on functional outcome in lower-extremity soft-tissue sarcomaC H Gerrand
University Musculoskeletal Oncology Unit, Mount Sinai Hospital, Toronto, Ontario, Canada
Ann Surg Oncol 11:476-82. 2004..Anatomical location is not a significant predictor of aggregated MSTS and TESS evaluations. However, there is variation in MSTS and TESS item scores across anatomical locations...
Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcomaN Gokgoz
Fred A. Litwin Center for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
Cancer 92:2181-9. 2001..The current data indicate that p53 mutations are not late events in osteosarcoma tumor progression, because they are evident before the development of metastases. The inclusion of exons 4 and 10 increased the sensitivity of the analysis...
Topotecan and cyclophosphamide in adults with relapsed sarcomaP Blanchette
Department of Internal Medicine, University of Toronto, Toronto, Canada
Sarcoma 2012:749067. 2012..7 months, all but 1 patient had died of disease. Conclusion: TC combination is tolerable but has only modest activity in adults with recurrent sarcoma. Other regimens deserve exploration for this high-risk group of patients...
Soft tissue sarcomas involving the pelvisS J Lewis
University Musculoskeletal Oncology Unit, Mount Sinai Hospital, Department of Surgical Oncology, Toronto, Ontario, Canada
J Surg Oncol 77:8-14; discussion 15. 2001..CONCLUSIONS: Soft tissue sarcoma of the pelvis is fortunately a rare disease with a high risk of local and systemic disease progression despite treatment with irradiation and surgical resection...
The efficacy of chemical adjuvants on giant-cell tumour of bone. An in vitro studyY Gortzak
Mount Sinai Hospital, Toronto, Canada
J Bone Joint Surg Br 92:1475-9. 2010..No multinucleated cell formation was seen in these cultures. These results suggest that the use of chemical adjuvants other than water could help improve local control in the treatment of GCT of bone...
Clinical features, treatment, and outcome in 102 adult and pediatric patients with localized high-grade synovial sarcomaH Al-Hussaini
Division of Medical Oncology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada M5G 2M9
Sarcoma 2011:231789. 2011..Conclusions. Patients with localized SS have a good chance of cure with surgery and RT. Evidence for a well-defined role of chemotherapy to improve survival In localized SS remains elusive...
Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcomaA M Davis
Toronto Rehabilitation Institute, Princess Margaret Hospital, University of Toronto, Ontario, Canada
J Clin Oncol 20:4472-7. 2002..Functional outcome and health status of extremity STS patients randomized in a phase III trial comparing preoperative versus postoperative RT is described...
Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomasJ S Wunder
Department of Surgery, University of Toronto, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Canada
Oncogene 18:783-8. 1999..The different patterns of gene amplification and overexpression of CDK4, SAS and MDM2 in parosteal and intramedullary osteosarcomas may help explain the disparity in the biological behaviour of these two types of osteosarcoma...
Transarticular invasion of bone tumours across the sacroiliac jointS Chhaya
Department of Medical Imaging, Mount Sinai Hospital and the University Health Network, University of Toronto, Toronto, Canada
Skeletal Radiol 34:771-7. 2005....
Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcomaSalvador Mejia-Guerrero
Fred A Litwin Centre for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada
Genes Chromosomes Cancer 49:518-25. 2010..There was no association with other clinical parameters. In conclusion, co-amplification of MDM2 and CDK4 in two separate amplicons occurs frequently in parosteal OS and less so in classical high-grade OS...
Free tissue transfer and deep vein thrombosisDylan J Murray
Division of Plastic Surgery, University Health Network, University of Toronto, Toronto, Ontario, Canada
J Plast Reconstr Aesthet Surg 61:687-92. 2008....
Prognosis of radiation-induced bone sarcoma is similar to primary osteosarcomaMahmood Shaheen
University Musculoskeletal Oncology Unit, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada
Clin Orthop Relat Res 450:76-81. 2006..LEVEL OF EVIDENCE: Therapeutic study, level IV-1...
Giant cell tumor of bone express p63Brendan C Dickson
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada
Mod Pathol 21:369-75. 2008..Moreover, p63 may be a useful biomarker to differentiate giant cell tumor of bone from central giant cell granuloma and other giant cell-rich tumors, such as giant cell tumor of tendon sheath and pigmented villonodular synovitis...
Altered expression and deletion of RMO1 in osteosarcomaKolja Eppert
Fred A Litwin Centre for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
Int J Cancer 114:738-46. 2005..Northern blot analysis indicated that RMO1 mRNA is ubiquitously expressed in tissues except for peripheral blood leukocytes. These data suggest that RMO1 may be a candidate for a protein involved in inhibiting tumor progression...
COPS3 amplification and clinical outcome in osteosarcomaTaiqiang Yan
Fred A Litwin Centre for Cancer Genetics, Mount Sinai Hospital, and University Musculoskeletal Oncology Unit, Toronto, Ontario, Canada
Cancer 109:1870-6. 2007..To determine the relation between COPS3 amplification, P53 mutation, and patient outcome in osteosarcoma, tumors from a large cohort of patients with high-grade osteosarcoma and long-term clinical follow-up were examined...
Cyclin alterations in giant cell tumor of boneAdel Kauzman
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, M5G 1X5, Canada
Mod Pathol 16:210-8. 2003..These results suggest that alterations in cyclin D1 and/or D3 might play a role in the pathogenesis of giant cell tumor of bone...
Clinical and functional outcomes of patients with a pathologic fracture in high-grade osteosarcomaPeter C Ferguson
Division of Orthopaedic Surgery, Mount Sinai Hospital, Department of Surgery, University Musculoskeletal Oncology Unit, University of Toronto, Toronto, Ontario, Canada
J Surg Oncol 102:120-4. 2010..There have been variable reports of outcomes of patients with osteosarcoma and pathologic fractures. The purpose of this study was to document outcomes after management of this clinical entity at a single large oncology center...
Iliosacral resection for primary bone tumors: is pelvic reconstruction necessary?Gordon P Beadel
University Musculoskeletal Oncology Unit, Mount Sinai Hospital, Toronto, Ontario, Canada
Clin Orthop Relat Res 438:22-9. 2005..LEVEL OF EVIDENCE: Therapeutic study, Level III-1 (case-control study). See the Guidelines for Authors for a complete description of levels of evidence...
von Willebrand factor expression in osteosarcoma metastasisKolja Eppert
Fred A Litwin Centre for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
Mod Pathol 18:388-97. 2005..These findings suggest that vWF expression is deregulated in osteosarcoma tumors, potentially contributing to metastasis...
Eosinophilic granuloma. A different behaviour in children than in adultsF Plasschaert
Hospital for Sick Children and the Mount Sinai Hospital, Toronto, Canada
J Bone Joint Surg Br 84:870-2. 2002..By contrast, four of 13 skeletally mature patients had a recurrence and required further surgery. This suggests that eosinophilic granuloma has a low rate of recurrence in skeletally immature patients...
Oncologic and functional outcome of scapular chondrosarcomaAnthony M Griffin
University Musculoskeletal Oncology Unit at Mount Sinai Hospital, The University of Toronto, Suite 476G, 600 University Avenue, Toronto, Canada
Ann Surg Oncol 15:2250-6. 2008..The purpose of this study was to investigate both the oncologic and functional outcomes of patients presenting to a large oncology center with primary chondrosarcoma of the scapula...
Parathyroid hormone-related protein regulates glioma-associated oncogene transcriptional activation: lessons learned from bone development and cartilage neoplasiaBenjamin A Alman
Program in Developmental and Stem Cell Biology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
Ann N Y Acad Sci 1144:36-41. 2008..Thus, activation of a G protein-coupled receptor can negatively regulate hedgehog-mediated transcription independent of hedgehog ligand activity, raising intriguing therapeutic possibilities...
Functional outcomes after treatment of aggressive tumors in the distal radiusShannon K T Puloski
The University Musculoskeletal Oncology Unit, Mt Sinai Hospital, Toronto, Ontario, Canada
Clin Orthop Relat Res 459:154-60. 2007..Whenever possible, joint preservation is preferable for the result of better extremity function, but weaker grip, higher local tumor relapse, and late arthritis remain concerns...
Joint salvage for pathologic fracture of giant cell tumor of the lower extremityBenjamin M Deheshi
University Musculoskeletal Oncology Unit, Mount Sinai Hospital, Toronto, Ontario, Canada
Clin Orthop Relat Res 459:96-104. 2007..Joint salvage for patients with pathologic fractures through giant cell tumor of weightbearing bones is a reasonable option with functional outcomes and recurrence rates comparable to those of patients without fracture...
CYP3A4/5 and pharmacogenetics in patients with sarcoma - Authors' replyJay S Wunder
University Musculoskeletal Oncology Unit and Program in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
Lancet Oncol 8:668-9. 2007
Gli2 and p53 cooperate to regulate IGFBP-3- mediated chondrocyte apoptosis in the progression from benign to malignant cartilage tumorsLouisa Ho
Program in Developmental and Stem Cell Biology, Hospital for Sick Children, University of Toronto, ON, Canada
Cancer Cell 16:126-36. 2009..IGF signaling-meditated apoptosis regulates the progression to malignant chondrosarcoma...
hCDC4 variation in osteosarcomaTaiqiang Yan
Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, M5G 1X5
Cancer Genet Cytogenet 169:138-42. 2006..We conclude that somatic hCDC4 mutations are infrequent in osteosarcoma, and are unlikely to play an important role in aneuploidy of this tumor...
Work status after distal femoral Kotz reconstruction for malignant tumors of boneAndrea Brown
University Musculoskeletal Oncology Unit, and Department of Rehabilitation Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
Arch Phys Med Rehabil 84:62-8. 2003..Baseline job demand and living environment (rural vs urban, P=.001) were predictive by logistic regression. CONCLUSIONS: Patients with physically demanding jobs, and those living rurally, are at greatest risk for altered work status...
Osseous invasion by soft-tissue sarcoma: assessment with MR imagingDavid A Elias
Departments of Diagnostic Imaging, Pathology and Laboratory Medicine, Mount Sinai Hospital and the University Health Network, University of Toronto, 600 University Ave, Toronto, Ontario, Canada M5G 1X5
Radiology 229:145-52. 2003..001). CONCLUSION: On T1- and T2-weighted MR images, findings of cortical and medullary signal intensity change and cortical destruction were sensitive and specific for detection of osseous invasion by soft-tissue sarcoma...
Carbonic anhydrase IX as a marker for poor prognosis in soft tissue sarcomaKårstein Måseide
Ontario Cancer Institute Princess Margaret Hospital, Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
Clin Cancer Res 10:4464-71. 2004..The aim of this study was to quantify the extent of CA IX expression and to investigate whether CA IX is a marker for poor prognosis in soft tissue sarcoma patients at high risk of developing metastasis...
Periprosthetic bone remodeling around a prosthesis for distal femoral tumors: longitudinal follow-upAileen M Davis
Toronto Rehabilitation Institute, Toronto, Canada
J Arthroplasty 20:219-24. 2005..Key words: DEXA, stress shielding, uncemented endoprothesis, tumor, bone loss...
Maternal and neonatal outcomes in pregnancies complicated by bone and soft-tissue tumorsCynthia Maxwell
Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
Obstet Gynecol 104:344-8. 2004..Primary bone and soft-tissue tumors occur rarely in pregnancy. The objective of this study was to describe the outcome of a large cohort of pregnant patients with these rare tumors...
Outcome in two groups of patients with allograft-prosthetic reconstruction of pelvic tumor defectsGordon P Beadel
University Musculoskeletal Oncology Unit, Mount Sinai Hospital, Toronto, Ontario, Canada
Clin Orthop Relat Res 438:30-5. 2005..Group 2 patients had no infections and better functional results. LEVEL OF EVIDENCE: Therapeutic study, Level IV-1 (case series). See the Guidelines for Authors for a complete description of levels of evidence...
A mutant PTH/PTHrP type I receptor in enchondromatosisSevan Hopyan
Program in Developmental Biology, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada
Nat Genet 30:306-10. 2002..The mutant receptor constitutively activates Hedgehog signaling, and excessive Hedgehog signaling is sufficient to cause formation of enchondroma-like lesions...
Aseptic loosening is uncommon with uncemented proximal tibia tumor prosthesesMichael N Flint
University Musculoskeletal Oncology Unit, Mount Sinai Hospital, 476E-600 University Avenue, Toronto, Ontario M5G 1X5, Canada
Clin Orthop Relat Res 450:52-9. 2006..Aseptic loosening is uncommon with uncemented proximal tibia reconstruction, but decreasing other complications at this location remains challenging. LEVEL OF EVIDENCE: Therapeutic study, level IV-1 (case series)...
Bone invasion in extremity soft-tissue sarcoma: impact on disease outcomesPeter C Ferguson
University Musculoskeletal Oncology Unit, Mount Sinai Hospital, Toronto, Ontario, Canada
Cancer 106:2692-700. 2006..The purpose of the current study was to evaluate histologic bone invasion as a predictor of oncologic outcome in extremity soft-tissue sarcoma (STS) patients presenting to a specialty sarcoma center between 1986 and 2001...
Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferationTri Dung Tiet
The Hospital for Sick Children, 555 University Ave, Suite S107, Toronto, Ontario, Canada, M5G 1X8
Am J Pathol 168:321-30. 2006..Our data raise the intriguing possibility that Hedgehog blockade could serve as an effective treatment for chondrosarcoma, a tumor for which there are currently no universally effective nonsurgical management options...
Uncemented tumor endoprostheses at the knee: root causes of failureAnthony M Griffin
University Musculoskeletal Oncology Unit, Mount Sinai Hospital, Toronto, Ontario, Canada
Clin Orthop Relat Res 438:71-9. 2005..LEVEL OF EVIDENCE: Therapeutic study, level IV-1 (case series)...
Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesisWenyong Chen
Cancer Biology Program, Johns Hopkins Medical Institutions, 1650 Orleans Street, Baltimore, MD 21231, USA
Cancer Cell 6:387-98. 2004..Our results indicate the importance of genes altered only through epigenetic mechanisms in cancer progression in conjunction with genetically modified tumor suppressor genes...
Large segment allograft survival is improved with intramedullary cementCraig H Gerrand
North of England Bone and Soft Tissue Tumour Service, Newcastle-upon-Tyne, United Kingdom
J Surg Oncol 84:198-208. 2003....
Patched-one or smoothened gene mutations are infrequent in chondrosarcomaTaiqiang Yan
Department of Orthopaedic Oncology, People s Hospital, Beijing University, Beijing, China
Clin Orthop Relat Res 466:2184-9. 2008..4%) control subjects without cartilage tumors, suggesting it may represent a rare SMO variant. Constitutive activation of the hedgehog signaling pathway in chondrosarcoma is rarely caused by PTCH-1 or SMO mutations. [corrected]..
Two-stage revision of infected uncemented lower extremity tumor endoprosthesesMichael N Flint
Orthopaedic Oncology Unit, Middlemore Hospital, Auckland, New Zealand
J Arthroplasty 22:859-65. 2007..Two-stage revision of uncemented tumor endoprostheses with retention of a well-ingrown stem can be associated with successful eradication of infection...
Outcome after pelvic sarcoma resection reconstructed with saddle prosthesisFawzi Aljassir
McGill University Health Centre, Montreal, Canada
Clin Orthop Relat Res 438:36-41. 2005..LEVEL OF EVIDENCE: Therapeutic study, Level IV-1 (case series without control group). See the Guidelines for Authors for a complete description of levels of evidence...
